SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Ritz who wrote (10663)2/11/1999 2:07:00 PM
From: Anthony@Pacific  Read Replies (3) | Respond to of 122087
 
ENMD<-------SHORT @ 26 3/4!!! 100%



To: Ritz who wrote (10663)2/11/1999 2:09:00 PM
From: Mama Bear  Read Replies (1) | Respond to of 122087
 
Ritz, what does the quote tell us? All it tells me is that the mo mo crowd is running it up. They don't need a particularly good reason to do that, either.

I have CNBC turned off today. It gives me a headache.

Barb




To: Ritz who wrote (10663)2/11/1999 2:35:00 PM
From: Doorman  Respond to of 122087
 
No I wasn't - price must have shot up when B Globe article got picked up.

Bristol pulls out of Angiostatin yesterday and story of data validation on their other drug Endostatin gets national coverage the next day. Weird timing BUT NIH still needs to confirm mouse results at their own lab. And we're talking pre-clinical results. The fundamental picture still hasn't changed except for speculators craving action.

Glad my original short was only 1/3.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News